Directorate Change

RNS Number:9581D
Bespak PLC
02 June 2006


                                   Bespak plc

                   Paul Boughton appointed Executive Director


Bespak plc ("Bespak"), a leader in the design and manufacture of medical devices
for inhaled drug delivery and anaesthesia, is pleased to announce the
appointment of Paul Boughton as Executive Director.

Paul joined Bespak in August 2005 as Corporate Development Director. Prior to
that he was Business Development Director, and a member of the Board of Spectris
plc. He is currently a non-executive director of Raymarine plc where he also
chairs the audit committee. He was a non-executive director of London Bridge
Software plc from 1999 to 2004.

Age 50, Paul has extensive financial and business development experience gained
over 20 years in the area of high-tech manufacturing. Having graduated with a
degree in business economics, Paul qualified as a chartered accountant with
Deloitte Haskins & Sells before moving into industry.

Commenting on this appointment, John Robinson, Chairman, said:

"I am delighted to welcome Paul to the Board of Bespak. He has already made a
significant contribution to the development of our business, and with his
extensive and relevant experience I look forward to his contribution to the
Board."

Paul Boughton said:

"I am delighted to be joining the Board at such an exciting time for Bespak. The
acquisition of King Systems has significantly diversified our revenues and
provides an additional platform for growth, while the recently launched Exubera
(R) device is the first to deliver inhaled insulin. I look forward to continuing
to work closely with Mark Throdahl and the management team to help shape Bespak
for continuing success."

In accordance with Listing Rule 9.6.15, it is confirmed that there are no 
details to be disclosed pursuant to Listing Rule 9.6.13.


For further information please contact:

Bespak
John Robinson, Chairman             Tel: [phone]
Mark Throdahl, Chief Executive      Tel: + 44 (0)1908 552600

Maitland
Brian Hudspith or Liz Morley       Tel: [phone]


Bespak plc is a leader in specialty medical devices, developing delivery systems
for the pharmaceutical industry and disposable airway management products for
critical care settings.

The company develops and manufactures a range of devices including metered dose
inhalers, dry powder devices, actuators, compliance aids, disposable facemasks,
breathing circuits and laryngeal tubes. The group holds the 2005 Frost &
Sullivan Award for Technology Innovation and has facilities in King's Lynn and
Milton Keynes in the UK, in Indianapolis, Indiana and Kent, Ohio, in the US and
in Mumbai, India. Bespak is a public company quoted on the full list of the
London Stock Exchange (LSE: BPK).






                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
BOAUUUQCQUPQURP